Hughes Terig
SEC CIK 1841309 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| VNRX | VOLITIONRX LTD | CFO | 685.0K | — | — | 18 | 2022-04-07 | 2026-02-26 |
Most active insiders at VNRX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Reynolds Cameron John | Pres, CEO, Dir | $63.1K | — |
| 2 | Innes Guy Archibald | Dir | $49.0K | — |
| 3 | STILL TIMOTHY I | Dir | $24.5K | — |
| 4 | Rubin Ethel | Dir | — | — |
| 5 | Retter Andrew | Chief Medical Off | — | — |
| 6 | Batchelor Ann-Louise | Group CMO | — | — |
| 7 | Henshall Mickie | Dir | — | — |
| 8 | Plummer Nicholas | GC - Volition Diagnostics | — | — |
| 9 | Nguyen Kim | Dir | — | — |
| 10 | Forterre Gael | Chief Commercial Off | — | — |
| 11 | Hughes Terig | CFO | — | — |
Transactions 18
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-27 | 2026-02-26 | VNRX | VOLITIONRX LTD | Hughes Terig | CFO | A - Grant | $0.00 | +202.0K | 685.0K | +42% | $0 | |
| 2026-01-23 | 2026-01-22 | VNRX | VOLITIONRX LTD | Hughes Terig | CFO | A - Grant | $0.00 | +49.2K | 483.0K | +11% | $0 | |
| 2025-08-19 | 2025-08-15 | VNRX | VOLITIONRX LTD | Hughes Terig | CFO | A - Grant | $0.00 | +26.1K | 533.8K | +5% | $0 | |
| 2025-07-25 | 2025-07-24 | VNRX | VOLITIONRX LTD | Hughes Terig | CFO | A - Grant | $0.00 | +100.0K | 507.6K | +25% | $0 | |
| 2025-06-03 | 2025-06-01 | VNRX | VOLITIONRX LTD | Hughes Terig | CFO | A - Grant | $0.00 | +17.4K | 407.6K | +4% | $0 | |
| 2025-03-04 | 2025-03-01 | VNRX | VOLITIONRX LTD | Hughes Terig | CFO | A - Grant | $0.00 | +14.0K | 390.2K | +4% | $0 | |
| 2024-12-03 | 2024-12-01 | VNRX | VOLITIONRX LTD | Hughes Terig | CFO | A - Grant | $0.00 | +12.7K | 376.3K | +3% | $0 | |
| 2024-09-04 | 2024-09-01 | VNRX | VOLITIONRX LTD | Hughes Terig | CFO | A - Grant | $0.00 | +13.5K | 363.6K | +4% | $0 | |
| 2024-08-16 | 2024-08-15 | VNRX | VOLITIONRX LTD | Hughes Terig | CFO | A - Grant | $0.00 | +19.5K | 350.1K | +6% | $0 | |
| 2024-06-04 | 2024-06-01 | VNRX | VOLITIONRX LTD | Hughes Terig | CFO | A - Grant | $0.00 | +11.7K | 330.6K | +4% | $0 | |
| 2024-01-26 | 2024-01-24 | VNRX | VOLITIONRX LTD | Hughes Terig | CFO | A - Grant | $0.00 | +33.1K | 318.9K | +12% | $0 | |
| 2023-10-20 | 2023-10-19 | VNRX | VOLITIONRX LTD | Hughes Terig | CFO | A - Grant | $0.00 | +100.0K | 285.7K | +54% | $0 | |
| 2023-07-07 | 2023-07-05 | VNRX | VOLITIONRX LTD | Hughes Terig | CFO | A - Grant | $0.00 | +24.8K | 185.7K | +15% | $0 | |
| 2023-01-13 | 2023-01-12 | VNRX | VOLITIONRX LTD | Hughes Terig | CFO | A - Grant | $0.00 | +20.6K | 161.0K | +15% | $0 | |
| 2022-10-14 | 2022-10-13 | VNRX | VOLITIONRX LTD | Hughes Terig | CFO | A - Grant | $0.00 | +9,625 | 140.4K | +7% | $0 | |
| 2022-10-06 | 2022-10-04 | VNRX | VOLITIONRX LTD | Hughes Terig | CFO | A - Grant | $0.00 | +100.0K | 130.7K | +325% | $0 | |
| D | 2022-06-24 | 2022-06-23 | VNRX | VOLITIONRX LTD | Hughes Terig | CFO | A - Grant | $0.00 | +20.0K | 30.7K | +186% | $0 |
| D | 2022-04-08 | 2022-04-07 | VNRX | VOLITIONRX LTD | Hughes Terig | CFO | A - Grant | $0.00 | +10.8K | 10.8K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations